David DeCaprio - 10 Mar 2025 Form 4 Insider Report for FIREFLY NEUROSCIENCE, INC. (AIFF)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Mar 2025, 18:05:06 UTC
Prior SEC filing
12 Mar 2025
Next SEC filing
22 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David DeCaprio

Key filing fact

David DeCaprio filed Form 4 for FIREFLY NEUROSCIENCE, INC. (AIFF) on 12 Mar 2025.

Key facts

  • This page summarizes David DeCaprio's Form 4 filing for FIREFLY NEUROSCIENCE, INC. (AIFF).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Mar 2025, 18:05.

Change

  • Previous filing in this sequence was filed on 12 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AIFF transaction Derivative

Deferred Stock Units

Award

Transaction value
$0
Shares
+16,667
Change %
Price
$0.000000
Shares after
16,667
Date
10 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,667
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .